Transdermal delivery systems have been developed for local and systemic administration of drugs. Relationships between skin permeability and physicochemical properties of drugs have been investigated to clarify the mechanisms of skin permeation, as well as to predict plasma drug concentrations after applying transdermal delivery.
Transdermal delivery systems have been developed for local and systemic administration of drugs. Relationships between skin permeability and physicochemical properties of drugs have been investigated to clarify the mechanisms of skin permeation, as well as to predict plasma drug concentrations after applying transdermal delivery. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Skin permeation consists of sequential physical and biological processes. The partition and diffusion of drugs are recognized as important physical processes. Diffusion in skin tissue is determined by the molecular weight of drug. The influence of partition has been evaluated by correlating skin permeability with drug lipophilicity, such as the logarithm of noctanol/buffer partition coefficient (Log P). Passive transdermal absorption often exhibits a parabolic relationship with the maximum at intermediate lipophilicity, which is explained by a change in the rate-limiting step for skin permeation. [2] [3] [4] [5] [6] [7] For hydrophilic drugs the partition into stratum corneum is the rate-limiting step of skin permeation, whereas for lipophilic drugs the partition between stratum corneum and viable epidermis becomes important.
Iontophoresis is a physical method for enhancing skin permeation of drugs via an electrical potential gradient through the skin. 12) During the last 2 decades, iontophoretic transdermal delivery has been successfully developed for basic and clinical uses. [12] [13] [14] [15] Nevertheless, there are limited reports on the relationship between iontophoretic absorption rate and drug properties. 12, [16] [17] [18] [19] [20] [21] [22] [23] Excised skin from human or animals has been employed to measure in vitro skin permeability of drugs. It is pointed out, however, that their preparation methods, storage conditions and hydration before use influence the drug permeability. 20, [24] [25] [26] [27] [28] [29] [30] [31] Thus, the objective of our study was to evaluate the effect of drug properties on transdermal delivery under in vivo conditions. In this report, we focused on the effect of drug lipophilicity on iontophoretic absorption. Non-steroidal anti-inflammatory drugs (NSAIDs) were selected as model drugs with a wide range of lipophilicity: salicylic acid (SA), ketoprofen (KP), naproxen (NP) and indomethacin (IM). Table 1 lists the physicochemical data of these NSAIDs. 3, [32] [33] [34] The Log P values at pH 7.4 (donor drug solution) are in the range of Ϫ2.18 to 1.32.
Transdermal drug absorption includes the following processes: (1) drug absorption into the skin; (2) the transfer from skin to cutaneous vein; (3) the transport to systemic circulation by blood flow. In order to evaluate these absorption processes, we previously determined drug concentrations in skin, cutaneous vein and systemic vein after the iontophoretic delivery of drug. 36) Moreover, kinetic analysis of drug transfer from skin to cutaneous vein was developed by modifying a physiological pharmacokinetic model. 37) In the present study, cathodal iontophoresis of NSAIDs to rats was performed under a constant electrical current, and the effect of drug lipophilicity on the absorption processes was investigated. In the experiment, the drug solution adjusted to pH 7.4 was placed in the cathodal reservoir. Although the pK a of SA is different from the other NSAIDs used, the degrees of ionization of all NSAIDs are approximately 100% at pH 7.4 (Table 1) . Therefore, because the negatively charged forms of NSAIDs are mainly absorbed into the skin during cathodal iontophoresis, we assumed that the difference in pKa would not influence the transdermal iontophoresis of the NSAIDs examined.
NSAIDs are used in clinical treatment of inflammatory diseases such as rheumatoid arthritis, but a variety of gas- trointestinal side effects are associated with their oral administration. 38) Alternatively, transdermal delivery of NSAIDs is expected to avoid the side effects. However, the commercialized conventional formulations (gel and tape) are available only for treatment of local sites, because systemic plasma concentrations are low. 38) In contrast, since the iontophoretic enhancement of skin permeation could increase the systemic levels of NSAIDs, transdermal delivery might enable systemic therapy. Cathodal Iontophoresis Cathodal iontophoresis was performed as described previously. 36, 37) Briefly, male SpragueDawley rats (8-10 weeks old, Charles River Japan) were anesthetized with ether throughout the experiment, and their body temperature was maintained at 37°C using a heating pad. The hair of the skin was removed by electrical clippers. The NSAID examined was dissolved in 50 mM phosphate buffer solutions (0.5 mg/ml) and adjusted to pH 7.4 with 1 M HCl and NaOH. The drug and buffer solution were placed in reservoirs, respectively (Fig. 1) . A constant direct current of 0.625 mA/cm 2 was applied for up to 90 min, using platinum electrodes. After iontophoresis, blood samples were collected from lateral thoracic vein (cutaneous vein) and inferior vena cava (systemic vein), respectively (Fig. 1) . Whole skin was excised from the corresponding area of the application site and homogenized with saline/acetonitrile (1 : 1, v/v). All NSAIDs used were soluble in the donor solution throughout the experiment.
MATERIALS AND METHODS

Chemicals and Reagents
In Vitro Drug Distribution in Rat Blood Partition coefficients of NSAIDs between whole blood and plasma (C b /C p ) were evaluated by the method of Fujieda et al. 39) After pre-incubation of heparinized rat blood at 37°C, drug solution (10 ml) at 0.05, 0.1, 0.5, 1.0, 2.0 and 5.0 mg/ml was added to the blood (500 ml). The blood samples were incubated at 37°C for 10 min and centrifuged at 3000 rpm for 10 min to obtain plasma.
Assays Plasma drug concentration was determined by HPLC measurements. The plasma (100 ml) was acidified by adding 1 M HCl (100 ml), then extracted with diethyl ether (5 ml). The ether layer was separated by centrifugation (3000 rpmϫ10 min, 4°C) and evaporated to dryness under a nitrogen stream. The mobile phase of the HPLC (200 ml) was added to dissolve the residue. A 100 ml aliquot of the final preparation was injected into an octadecyl reversed-phase column (YMC-Pack ODS-AM312, 150ϫ6.0 mm i.d., S-5 mm, 120 Å). Analytical conditions are listed in Table 2 . Drug concentration in the supernatant of skin homogenate was measured by HPLC without further treatment.
Data Analysis Kinetic analysis was described previously. 37) Briefly, the rate of local drug transfer from skin to cutaneous vein (R SC ) can be obtained from the arterio-venous blood concentration difference in the skin:
where Q b is a blood flow rate in the skin. C Artery and C Vein represent the drug concentration in arterial blood entering the skin, and in venous blood leaving the skin, respectively. C Artery and C Vein can be replaced by systemic and cutaneous plasma concentration (C p,Systemic and C p,Cutaneous , respectively), yielding (2) where Q b (C b /C p ) denote an effective plasma flow rate. R SC was calculated from Eq. 2 and normalized by area of application site. Lateral thoracic vein passing through the skin below application site was selected as cutaneous vein for blood sampling (Fig. 1) . It should be noted that this vein includes blood flow from the skin other than at the application site, and the plasma drug concentration obtained is underestimated by dilution due to venous mixing. Therefore, our study was lim- ited to relative evaluation of local absorption processes, and an estimation involving total body disposition was avoided. The NSAIDs used in our study are regarded as hydrophilic drugs. In general, the rate-limiting step in transdermal absorption of hydrophilic drugs is stratum corneum penetration, but not viable epidermis penetration and the subsequent transfer to cutaneous vein. 2, 3) Therefore, although an increase in cutaneous blood flow by iontophoresis is reported, 40, 41) it is considered that the influence of blood flow rate on the transdermal absorption of NSAIDs is not significant. Thus, Q b was assumed to be constant in calculation of R SC and the literature value of 44.6 ml/min/100 g skin, 42) corrected by skin weight, was adopted to Q b in Eq. 2.
Because the electrical resistance of blood in skin is negligible, we presumed that the ionized percentage and the distribution (C b /C p and protein binding, etc.) of NSAIDs in blood were not influenced by the electrical current in the iontophoresis. In addition, C b /C p values determined from in vitro distribution experiments were used for calculation of R SC . Because the collected rat blood was immediately used for the experiments, we assumed that the C b /C p values obtained under in vitro conditions could be approximated to those under in vivo conditions. Table 3 lists the partition coefficients of NSAIDs between whole blood and plasma (C b /C p ). The C b /C p values of SA, KP and NP were similar to each other. The value for IM was slightly lower than for the other drugs but not significantly. The mean values of C b /C p were used for calculation of effective plasma flow rate (Eq. 2). Figure 2 shows time-course curves of drug concentrations in skin, cutaneous vein and systemic vein during cathodal iontophoresis, respectively. Drug concentrations in the skin increased immediately after starting iontophoresis and reached steady states at 15-30 min, regardless of drug. Data at 90-min were plotted against Log P at pH 7.4 (Fig. 3A) . The dependence of lipophilicity is in the following order: SAϭKPϭNPϽIM. The absorption of IM into skin was the highest of the drugs tested. This result may imply high partition into stratum corneum due to the hydrophobic nature of IM. On the other hand, the partition of hydrophilic SA into stratum corneum was presumed to be low. However, the skin concentration of SA was similar to KP and NP. This finding suggests that the skin absorption of a hydrophilic drug is increased by iontophoretic enhancement.
RESULTS AND DISCUSSION
Partitioning of NSAID in Rat Blood
Skin Concentration
Cutaneous Plasma Concentration The time-courses of cutaneous plasma concentrations displayed a similar tendency to skin concentrations (Fig. 2) . The cutaneous plasma concentrations increased immediately after starting iontophoresis and reached steady-state concentrations at 15-30 min, regardless of drug. These results suggest that local ab- sorption processes in the skin reach steady states at 15-30 min. Cutaneous plasma concentrations at 90 min were in the following order: SAϾKPϭNPϾIM (Fig. 3B) , which appeared to be opposite to the case of skin absorption (Fig.  3A) . Cutaneous plasma concentration of IM was lowest among the NSAIDs tested, but the skin concentration was highest. These results suggest that the transfer of IM from skin to cutaneous vein is lower than with the other NSAIDs. Consequently, it is speculated that drug transfer from skin to cutaneous vein decreases with increasing lipophilicity: SAϾ KPϭNPϾIM. This speculation will be confirmed by kinetic analysis of transfer rate from skin to cutaneous vein (described below).
Systemic Plasma Concentration Systemic plasma concentrations increased slowly with time and steady states were not attained within 90 min (Fig. 2) . The dependence of systemic plasma concentration on drug lipophilicity (Fig. 3C) was consistent with that of cutaneous plasma concentration (Fig. 3B ). This result is explained by rapid drug transport from cutaneous vein to systemic circulation by blood flow.
Drug Transfer from Skin to Cutaneous Vein Drug transfer from skin to cutaneous vein was evaluated from the transfer rate (R SC ) and normalized R SC by skin concentration. Figure 4 shows the relationship between the R SC value and Log P at pH 7.4, in which the data at 30, 60 and 90 min are adopted, because local absorption processes in the skin reach steady state conditions after 30-min iontophoresis. In Fig. 4 , the R SC of SA is found to be higher than the other NSAIDs, and the R SC of IM is similar to KP and NP. These comparisons were obtained under different skin concentrations. Hence, to correct the contribution of skin concentration, the R SC value was normalized by skin concentration (X S ).
As shown in Fig. 5 , the R SC /X S value negatively correlates with the Log P at pH 7.4.
R SC /X S ϭϪ0.20 Log P(pH 7.4)ϩ0.49 rϭ0.838 (3) This finding indicates that drug transfer from skin to cutaneous vein decreases with increasing lipophilicity (SAϾ KPϭNPϾIM), consistent with the speculation described above. Although the NSAIDs used have different chemical structures, it is suggested that lipophilicity may be an important factor for drug transfer from skin to cutaneous vein. The negative correlation obtained in our study may resemble the lipophilic half of the parabolic relationship in passive absorption, explained by drug partitioning between stratum corneum and viable epidermis. In the case of hydrophilic drugs, the partitioning from stratum corneum to viable epidermis is higher, following the transport to cutaneous blood flow. On the other hand, lipophilic drugs exhibit poor partitioning to viable epidermis, resulting in a high accumulation in stratum corneum. These considerations are supported by the results in Fig. 3 : higher cutaneous plasma concentration for hydrophilic SA and higher skin concentration for The data for 90-min application were plotted against Log P at pH 7.4. lipophilic IM.
As described above, the negative correlation shown in Figs. 4 and 5 may reflect drug partitioning between stratum corneum and viable epidermis. It has been reported that the pH at the surface of stratum corneum is around 5, and in the stratum corneum the pH gradually increases to the physiological value at the stratum corneum-viable epidermal interface. [43] [44] [45] Therefore, we selected the Log P at pH 7.4 as an indication of drug property by assuming the transfer of NSAIDs from the deep layer of stratum corneum to viable epidermis (Figs. 4 and 5) . Furthermore, we estimated the influence of the surface pH of stratum corneum by plotting R SC and R SC /X S values against Log P at pH 5 (data not shown). The dependence on drug lipophilicity was not different from that shown in Figs. 4 and 5 . It is likely that the pH profile in stratum corneum may not strongly influence the partitioning of NSAIDs between stratum corneum and viable epidermis.
Comparison with Early Studies Investigation of transdermal absorption properties of drugs may lead to the selection of drugs and the design of delivery systems for local and systemic therapy. A number of researchers have reported studies involving NSAIDs. [3] [4] [5] 11, 46) These studies have been mostly based on the data from in vitro skin permeation experiments, but in vivo evaluation has been limited. Yano et al. and Lee et al. determined the in vivo absorption percentage of NSAIDs applied onto human and rat skin, respectively. 3, 4) However, it is considered that data of drug absorption into the skin alone cannot adequately predict systemic plasma concentrations, as well as the resulting systemic therapeutic effects. For example, as shown in Figs. 3A and C, skin absorption of IM was highest among the NSAIDs tested, but the systemic plasma concentration was minimal. Therefore, it is necessary to evaluate drug transfer from skin to cutaneous blood flow. Singh and Roberts demonstrated that the dependence of lipophilicity on drug clearance from rat dermis was not apparent with steroids (neutral drugs), NSAIDs (acidic drugs) and basic drugs. 46) Recently, Yagi et al. reported that the elimination rate constants of b-blocking agents from rat viable epidermis were not correlated with their lipophilicity. 47) The elimination process of drugs from the skin, evaluated in early studies, consists of not only drug transfer to cutaneous vein, but also deep tissue penetration below the skin. In our study, the measurement of cutaneous plasma concentration allows us to obtain direct information about drug transfer from skin to cutaneous vein and to discriminate from deep tissue penetration.
Roberts and Cross demonstrated drug transfer from skin to perfusate using an in situ perfused rat hindlimb model. 48) They showed that the transfer was dependent on the relative magnitude of drug binding in skin tissue and in perfusate. Because plasma protein binding of SA (ca. 85%) is lower than the other NSAIDs used in our study (Ͼ95%), 49, 50) the unbound fraction of SA is Ͼ3 times higher than the other NSAIDs. Accordingly, the difference in unbound fraction should be taken into account. The higher transfer of SA from skin to cutaneous vein might relate not only its hydrophilicity (higher partitioning from stratum corneum to viable epidermis), but also to higher concentrations of unbound SA in skin tissue and cutaneous blood.
The effects of the lipophilicity of compounds on in vitro iontophoretic delivery have been investigated in several studies. [18] [19] [20] [21] [22] [23] Del Terzo et al. reported that the skin permeability of n-alkanoic acids linearly decreased with increasing alkyl chain length of C1 to C8. 18) Green et al. reported that the permeability of amino acids and tripeptides decreased with an increase in Log P. 21, 22) These results indicate that the iontophoretic skin permeability depends on the lipophilicity of compounds. However, these researchers have not examined more complex drug molecules. We extended the early findings to the in vivo skin permeation of NSAIDs. Moreover, we could evaluate the effect of drug lipophilicity on transfer processes in skin permeation behavior. Del Terzo et al. reported that the reason for decreased skin permeability of lipophilic alkanoic acids is due to a decrease in the efficiency of entering the pore pathway in the skin. 18) To prove this hypothesis, we estimated the entering efficacy from our data on skin absorption (Fig. 3A) . It is likely that the hypothesis by Del Terzo et al. may not be appropriate, because of higher absorption for lipophilic IM. Thus, the contribution of other transfer processes should be considered. The decrease in in vitro skin permeability with increasing lipophilicity is consistent with the negative correlation of NSAIDs obtained in our study (Fig. 5) . Therefore, it is suggested that skin permeability may be determined by drug partitioning between stratum corneum and viable epidermis.
Possibility of Clinical Application Our results show that hydrophilic drugs exhibit high transfer properties to cutaneous vein. Therefore, SA is essentially appropriate to systemic therapy by iontophoretic transdermal delivery. However, the effective plasma concentrations for systemic therapy such as rheumatic diseases are in the range of 150-300 mg/ml. 38) This concentration is much higher than our data shown in Fig. 2 . Therefore, the iontophoretic delivery of SA for systemic therapy might be difficult.
Of all NSAIDs tested, IM has the highest anti-inflammatory activity, but the transdermal delivery displays a disadvantage compared to systemic therapy due to drug accumulation in the skin. In our study, iontophoretic delivery of IM produced systemic plasma concentrations up to 0.16 mg/ml (Fig. 2) . Pratzel et al. reported that the maximum plasma levels of IM after iontophoresis were 0.082 mg/ml (pig, 0.1 mA/cm 2 , 150 cm 2 ) and 0.221 mg/ml (human, 0.1 mA/cm 2 , 1380 cm 2 ). 51) By simple mathematics, these results by Pratzel et al. were converted into our application conditions (0.625 mA/cm 2 , 0.8 cm 2 ): 0.0027 mg/ml (pig) and 0.0008 mg/ml (human). These values are 1/60 and 1/200 of our results. Although the reasons are not clear, one possibility is the difference in formulation. Pratzel et al. used a gel formulation containing 1% IM (the composition was not described in detail), 51) in which the fraction of ionized IM may be low and the viscous nature of the gel may disturb the electrochemical migration of IM. Our results are one-third of the steady-state concentrations after long-term administration of the oral dosage form of IM, around 0.5 mg/ml. 51) Effective plasma levels might be achieved by a combination of iontophoresis and chemical enhancers which acted to decrease drug accumulation in the skin.
In conclusion, our study demonstrated the effect of drug lipophilicity on in vivo iontophoretic transdermal absorption of NSAIDs. Absorption into the skin was higher in the case of lipophilic drugs, whereas drug transfer from skin to cutaneous vein decreased with an increase in lipophilicity. More-over, the dependence of lipophilicity on cutaneous plasma concentration was similar to systemic plasma concentration. As a factor that determines the transfer of NSAIDs from skin to cutaneous vein, drug lipophilicity which related to the partitioning between stratum corneum and viable epidermis, as well as the unbound drug concentrations in skin tissue and cutaneous blood were suggested. Further investigations are necessary to clarify the influence of other physicochemical properties (molecular size, charge, pK a , etc.) of drugs.
